Connecteve
1 known investors
Connecteve (Connective/CONNEVO) develops evidence-based AI models for healthcare, validated with over 100,000 images and supported by technology and image patents and published technical papers. The company focuses on connecting technologies to improve healthcare.
Also known as Connevo · CONNEVO · 코넥티브
Investors · 1
Company profile
researched Aug 2026CONNECTEVE (Korean: 코넥티브) is a healthcare technology company developing artificial intelligence software and robotics for orthopedics, operating under the product brand CONNEVO — a name the company describes as a combination of "CONNECTEVE" and the Latin "Recovo/revoco" (to revive or restore). Its stated positioning is to connect technologies across the care pathway to improve healthcare outcomes, with an emphasis on clinically proven technology, connected care and affordability.
The company's portfolio spans three areas. CONNEVO KOA is AI-based joint analysis software that uses X-ray imagery to assess osteoarthritis progression and produce reports intended to give clinicians rapid insight and patients a visual explanation of their joint condition; associated product names referenced include HERO KNEE, CONNEVO ALI and the CONNEVO Suite. CONNEVO Robot is a knee replacement surgical robot under development that replaces marker fixation and manual registration with scan-based registration: a structured-light 3D scanner captures high-precision surface data under bright operating-room lighting and auto-registers it in real time with CT-based surgical plans. The system pairs a 7-axis robotic arm with real-time robot–scanner synchronization, high-sensitivity sensors, multi-layer safety mechanisms, hygiene-optimized surfaces and high-speed camera monitoring of instrument and anatomical micro-motion. The company states this medical device is under regulatory approval and not yet available for sale. A third line, Life Care, is described as a life-care system delivered through appropriate treatment and management.
CONNECTEVE is led by CEO DuHyun Ro, an orthopedic surgeon, professor and researcher holding M.D., M.S. and Ph.D. degrees from Seoul National University College of Medicine, who serves in committee and editorial roles including Managing Editor of Clinics in Orthopedic Surgery and board membership of the Korean Society of Medical Robotics. The executive team includes CFO Sungsu Ban, CTO of the medical robot team Ho-Seong Kwak, Chief Business Officer Harris Lee, Chief Product Officer Hannah Cho, software division director Junghyun Do and robot division director Chunghun Ha, with additional team leads covering manipulator software, QA, product management, frontend development and regulatory affairs.
Business model
The company develops and commercializes proprietary medical software and hardware: AI diagnostic/analysis software for joints and an orthopedic surgical robot system, complemented by a life-care management offering. Products are positioned around outstanding performance at an affordable price with clinically proven, connected technology.
Latest developments
The CONNEVO surgical robot is stated to be under regulatory approval and not yet available for sale. The company maintains a regulatory affairs team and is actively recruiting.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions itself in orthopedics as a provider of clinically validated AI and next-generation knee surgical robotics, with its robot described as moving beyond marker fixation and manual registration used in existing approaches.
Differentiation is framed around scan-based registration using structured-light 3D scanning that operates under bright operating-room lighting, real-time CT plan registration, an integrated robot-and-scanner control solution, and AI models validated on a dataset of over 100,000 medical images backed by patents, copyright registrations and published technical papers.
Technology
Core technology combines X-ray-based AI models for osteoarthritis progression analysis with vision-guided surgical robotics. The robotic platform uses structured-light 3D scanning for scan-based registration in place of marker fixation and manual registration, real-time registration with CT-based surgical plans, synchronized robot–scanner control, a 7-axis robotic arm, high-sensitivity sensors, multi-layer safety mechanisms and high-speed camera monitoring. The company states its AI models were developed and validated with more than 100,000 medical images and reports 14 technology patent applications, 10 image patent applications, 25 image copyright registrations and 50 technical paper publications.
Go-to-market
Orthopedic surgeons and clinicians treating knee and joint conditions, and their patients, who receive visual reports explaining joint condition.
Geography
Headquartered in South Korea, with a Korean-language and English-language web presence.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 5
primary sources listed
- Connecteveconnecteve.com · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Connecteve do?
- Korean medical technology company building X-ray-based AI joint analysis software and a vision-guided knee surgery robot.
- Who are Connecteve's investors?
- Connecteve's investors include Kakao Ventures.